Schonck WA, Hovingh GK, Blom DJ, Tromp T, Cuchel M, Alnouri F, Raal FJ, Roeters van Lennep JE, Fahed AC, Catapano AL, Zwinderman AH, Stroes ESG, D'Erasmo L, Reeskamp LF; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry , Atherosclerosis, 415: 2026,120717

Ahmad Z, Agarwala A, Cuchel M, Barton Duell P, Hegele RA, Hudgins L, Jamison A, Kalra D, Khera A, Knowles JW, Kullo IJ, Morales A, Rothstein MA, Saseen JJ, Soffer DE, Warden BA, Weintraub WS, Williams L, Goldberg AC. Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association , J Clin Lipidol: 2026

David Y. Zhang, Marylyn D. Ritchie, Daniel J. Rader, Marina Cuchel A loss-of-function missense variant in ANGPTL3 exerts protective effects against kidney disease risk , Atherosclerosis Supplement , 407: 2025,120322

Mulder JWCM, Reijman MD, Kusters DM, Boersma E, Alnouri F, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Freiberger T, Groselj U, Harada-Shiba M, Hovingh GK, Iatan I, Ibarretxe D, Kayikcioglu M, Kim NT, Klingel R, Raal FJ, Reeskamp LF, Sadiq F, Schonck WAM, Tromp TR, Truong TH, Wiegman A, Roeters van Lennep JE; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era , J Am Coll Cardiol, 85: 2025,1898-1903

Arca M, D'Erasmo L, Cuchel M, J Blom D, Cegla J, Duell PB, Santos RD, O'Brien S. Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data , J Clin Lipidol: 2025

David Zhang, Marylyn Ritchie, Daniel Rader, Marina Cuchel A Loss-of-Function Missense Variant in ANGPTL3 Exerts Protective Effects Against Kidney Disease Risk , Arterioscerosis Thrombosis and Vascular Biology, 45(Suppl 1): 2025,We0092

Cuchel M, Bajaj A. Type 2 diabetes in familial hypercholesterolaemia: another look at traditional risk factors , Lancet Diabetes Endocrinol: 2024

Reijman MD, Tromp TR, Hutten BA, Hovingh GK, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Gallo A, Hudgins LC, Raal FJ, Ray KK, Sadiq F, Soran H, Groothoff JW, Wiegman A, Kusters DM; Homozygous Familial Hypercholesterolaemia International Clinical Collaborators (HICC); Children with Homozygous Hypercholesterolemia on Lipoprotein Apheresis: an International Registry (CHAIN) consortia. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries , Lancet Child Adolesc Health, 8(7): 2024,491-499

Gidding SS, Ballantyne CM, Cuchel M, de Ferranti S, Hudgins L, Jamison A, McGowan MP, Peterson AL, Steiner RD, Uveges MK, Wang Y. It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States , Glob Heart, 19: 2024,43

Alfaro G, Pendyala J, Sulewski M, Miller M, Vitali C, Cuchel M. Longitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: Cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case study , J Clin Lipidol: 2024